Friday 6 November 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024.

Revenue: −0.24%
EPS: +2.48%
Free cash flow: +17.4%
Total debt: +37.5%

Quarter to June 2026, against a year earlier

81.72 7.48 −8.39%

Follow ZTS

Alert me

Market cap: $33.9B
P/E: 13.4×
Fwd P/E: 14.2×
Dividend yield: 2.59%
F-score: 7/9
Altman Z: 5.73
Beneish M: −2.45
Dividend safety: 88/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Zoetis Inc. (ZTS) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Zoetis Inc. (ZTS) trades at a P/E ratio of 13.4×. Over the past ten years it has ranged from 11.4× (October 2026) to 70.6× (January 2016); the current reading is higher than 4% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 20.5× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ZTS/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Zoetis Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ZTS/metrics/pe-ratio">Zoetis Inc. (ZTS) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	21.1×	(29.00%)
FY2024	29.7×	(23.31%)
FY2023	38.8×	19.07%
FY2022	32.6×	(42.63%)
FY2021	56.8×	17.96%
FY2020	48.1×	14.14%
FY2019	42.1×	45.36%
FY2018	29.0×	(28.89%)
FY2017	40.8×	25.55%
FY2016	32.5×	(53.91%)

Period	P/E ratio	Change
Jun 2026	11.8×	(39.61%)
Mar 2026	19.6×	(7.29%)
Dec 2025	21.1×	(15.31%)
Sep 2025	24.9×	(8.09%)
42 more quarters	Free account

Against its own ten years

Low 11.4× High 70.6×

Ten-year median 38.0×

Current reading's percentile 4

Company	P/E ratio
VTRS Viatris Inc. compare	n/m
ELAN Elanco Animal Health Incorporated compare	n/m
ZTS Zoetis Inc.	13.4×
UTHR United Therapeutics Corporation compare	19.7×
HLN Haleon PLC Sponsored ADR compare	20.5×
NBIX Neurocrine Biosciences, Inc. compare	23.0×
TAK Takeda Pharmaceutical Co. compare	32.0×
RDY Dr. Reddy's Laboratories Ltd compare	44.4×
TEVA Teva Pharmaceutical Industries Ltd. compare	92.6×
Drug Manufacturers Specialty & Generic industry median	20.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Zoetis Inc. (ZTS) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ZTS

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ZTS

Stockrow Weekly